Bronchial Asthma Define bronchial asthma.o Describe types of bronchial asthma.o Discuss etiopathogenesis of asthma. o Describe morphological features.

Obstructive and restrictive lung diseases• Obstructive lung diseases Obstructive lung diseases • (i.e. increased resistance to air flow) include:-• 1. Bronchial Asthma.• 2. Emphysema.• 3. Chronic bronchitis.• 4. Bronchiectasis.• 5. Cystic fibrosis and bronchiolitis.

• Why should we care about asthma?

What is Asthma?• DefinitionDefinition: • Asthma is a chronic inflammatory disorder of the

airways that causes recurrent spasmodic episodes, due to increased hyperirritability or responsiveness of the bronchial tree to various stimuli.

• This associated with these clinical manifestations:• 1. Wheezing.• 2. Breathlessness.• 3. Chest tightness.• 4. Cough, particularly at night and/or in the early

morning.

It is manifested physiologically by a widespread narrowing of the air passages, which may be relieved spontaneously or as a result of therapy. Can not cure but can controlled.

Life threatening disease

How long this episodes taking place? (Mild, severe) (Min\hr)

Bronchial asthma risk factors

• 1- Atopy (allergic asthma- largest risk allergic asthma- largest risk factor- genetic).factor- genetic).• ______________________________________________________________ 2 – Environmental factors( viruses, occupational exposures, allergens, cold air, dust, smoking ,others… ).

____________________________________

3- family history.

________________________________________________________________________________________________

4- others……………..

Common triggers for asthma

Disease characteristics

Bronchial asthma Classifications Asthma may be categorized into types

• ____________________________________________ _______________________________________________ 3- Bronchoconstriction triggering agents -

include

( a) SeasonalSeasonal asthma ( b) Exercise-induced Exercise-induced asthma.

(c) Drug-inducedDrug-induced asthma (e.g., aspirin & NSAIDaspirin & NSAID). (d) O(d) Occupationalccupational asthma (e) Eemotional asthma . (f ) Asthmaticsthmatic bronchitisbronchitis in smokers.

_________________________________________ 4-Recent studies added three subphenotypes of

Asthma , based on Airway inflammation pattern.

1 -Atopic type (allergicallergic sensitizationsensitization, Extrinsic)Extrinsic)..

2 - Non-atopic type (No allergic No allergic sensitizationsensitization).

Asthma Types• 1- Atopic asthma (allergicallergic sensitizationsensitization, Extrinsic) Extrinsic) :

• Classic example of type I IgE-mediated hypersensitivity reaction.

• Usually encountered in patient known case of rhinitis, eczema.

• Genetic predisposition.• A positive family history of asthma is common.• Begins in childhood.

• Triggered by Triggered by environmental allergens, such as dusts, pollens, roach or animal dander, and certain types of foods., etc…

• DiagnosisDiagnosis: clinical diagnosis is essential +…………………………….: clinical diagnosis is essential +…………………………….• (a) Skin test : (a) Skin test : Using the offending antigen immediate wheal-

and-flare reaction.

• (b) Serum radioallergosorbent tests (called RAST): TO (b) Serum radioallergosorbent tests (called RAST): TO identify the presence of IgE specific for a panel of allergens.

Asthma Types 2. Non-atopic asthma: - Non allergic.on allergic.

- Triggered commonly Triggered commonly by Respiratory infection due to viruses (e.g., rhinovirus, parainfluenza virus).

- Family history: Family history: less common.

- Skin test:Skin test: reveals negative reaction.

- MechanismMechanism: It is thought that virus-induced

inflammation of the respiratory mucosa lowers the threshold of the subepithelial vagal receptors to irritants.

Asthma Types3- Bronchoconstriction triggering agents (a) Drug-Induced Asthma.- Aspirin-sensitive asthma + NSAID occurring

with recurrent rhinitis and nasal polyps.-Others examples: adrenergic antagonists, coloring agents .Commonly occurs in adult.

Mechanism: Aspirin inhibiting the cyclooxygenase pathway of

arachidonic acid metabolism without affecting the lipoxygenase route, thus tipping the balance toward elaboration of the bronchoconstrictor leukotrienes.

Asthma Types(b) Occupational Asthma. Caused or worsened by breathing in irritants on

the job. • Triggered\stimulated by:• 1) Fumes (epoxy resins, plastics)• 2) Metal and dusts (platinum, wood, cotton)• 3) Chemicals and Gases (formaldehyde, penicillin

products, toluene, enzymes).• 4) Animal substances (5) Plants • - Minute quantities & Repeated exposure. • - Mechanisms:• According to stimulus include:-• Type I hypersensitivity reactions .• Liberation of bronchoconstrictor substances.• Hypersensitivity responses of unknown origin.

Bronchial asthma

• 4- Pattern of the Airway inflammation :

• 1) Eosinophilic asthma.• 2) Neutrophilic asthma.• 3) Mixed inflammatory asthma.• 4) Pauci-granulocytic asthma.

• These subgroups may differ in their:• (a) Etiology.• (b) Immunopathology.• (c ) Response to treatment.

Recent studies

Asthma Pathogenesis-1GENETIC CONSIDERATIONSGenetic predisposition In case of Atopic asthma- type I

hypersensitivity

Inheritance of susceptibility genes (postulation) that makes individuals prone to develop strong TH2 reactions against environmental antigens (allergens)

Asthma Pathogenesis-21. The airway epithelium and submucosa contain

dendritic cells that capture &process antigen \allergens. Initial sensitization stimulate induction of TH2 cells.

2. TH2 cells secrete cytokines e.g.(IL-4, IL-5,IL-13) that promote allergic inflammation and stimulate B cells to produce IgE and other antibodies.

3. Action of Cytokins(a) IL-4 Production of IgE by B cells. (b)IL-5 Activates recruited eosinophils.(c ) IL-13 Mucus secretion(bronchial submucosal glands)

also Promotes IgE production by B cells.

Asthma Pathogenesis-3 (Early & Late reaction)

3. IgE coats submucosal mast cells.

4. Repeat exposure triggers the mast cells to release granule contents and produce cytokines and other mediators induce the early-phase (immediate hypersensitivity) reaction and the late-phase reaction

Asthma Pathogenesis-4 (Early reaction- Minutes)

- AntigensTh2+ IgE productionIgE binding to mast cells leads to Eosp. recruitment& release of primary mediators=

(Histamine, chemotactic factors, and secondary mediators i.e. leukotriens, prostaglandins, cytokines and neuropeptides). This results in:

(A) Bronchospasm- triggered by direct stimulation of subepithelial vagal (parasympathetic) receptors through both central and local reflexes .

(B) Secretion of mucus.(C) Variable degree of vasodilatation& increase

permeability.(D) Accumulation of leukocytes.

Asthma Pathogenesis-5 (Late reaction- Hours) - 6- 10 hr later, produces a continued state of airway hyperresponsiveness with eosinophilic and neutrophilic

infiltration. (steroid helpful to treat this stage)

Components: consists largely of inflammation with recruitment of leukocytes= ( Eosinophils, neutrophils, and more T cells).

- Leukocyte recruitment is stimulated by chemokines produced by mast cells, Epithelial cells (eotaxin ) and T cells, and by other cytokines.

- Outcome: persistent bronchospasm, edema, and necrosis of epithelial cells by The major basic protein of eosinophils.

Cellular sources of inflammatory mediators& their effects

Cells Mediators Effects

Mast cells Macrophages Eosinophils T lymphocytes Epithelial cells Fibroblasts Neurons Neutrophils Platelets? Basophils?

Histamine Endothelin-1 Leukotrienes Prostaglandins Thromboxane Bradykinin Tachykinins Reactive oxygen species Adenosine Anaphylatoxins Endothelins Nitric oxide Cytokines Growth factors

Bronchoconstriction Plasma exudation vasodilatation Mucus hypersecretion Structural changes (fibrosis, smooth hyperplasia, angiogenesis, mucus hyperplasia)

Destroying the airway epithelium

Acute phase Late-phase

Release of inflammatory mediators

IgE

Mast cell

Allergen

Muscle contraction

Mucus secretion

Recruitment of leukocytes

Epithelial cell injury

Muscle contraction

Mucus secretion

Atopic asthma

Morphology of Asthma - - Gross appearanceGross appearance: - Done in lungs necropsy-study 1. Over-inflated and failure to collapse with patchy

atelectasis (pt. dying with Status asthmaticus). 2. Occlusion of airways by gelatinous mucous &

exudate plugs (the bronchial branches up to terminal

bronchioles) Microscopic appearance: Microscopic appearance: 1.Edema, hyperemia, and inflammatory infiltrate (with

excess eosinophils) in the bronchial walls.

2.Increase in the size of submucosal glands (hypertrophy\ hyperplasia)

3.Patchy necrosis and shedding of epithelial cells.

Over time – features of airway remodeling.

Airway remodeling.1.Overall thickening of airway wall . Reduction of

diameter

2.Basement membrane fibrosis(BM thickening).

3.Increases muscle mass (Hypertrophy and/or

hyperplasia).

4.Increased in size and number of blood vessels.

5.Increase number of the submucosal glands.

6. Mucus metaplasia of epithelium.

7.Increased fibrogenic factors collagen type I,II “scar”

8.Irreversible Airflow obstruction.

Epithelial remodeling

• Epithelium is damaged• New blood vessels• New muscle• New mucosal cells• Collagen deposition

Bronchial asthma, microscopic

Investigating asthma

-1. Elevated eosinophil count in the peripheral blood &CBC.-2. Sputum smear- Whorled mucous plugs = Curschmann spirals. -3. Sputum smear- Charcot-Leyden crystals in the sputum (Specially in atopic asthma). (Sputum).-4. Sputum -Creola bodies (desquamated epithelial cells)-5. Skin Test-6. RAST test.

-1. Elevated eosinophil count in the peripheral blood &CBC.-2. Sputum smear- Whorled mucous plugs = Curschmann spirals. -3. Sputum smear- Charcot-Leyden crystals in the sputum (Specially in atopic asthma). (Sputum).-4. Sputum -Creola bodies (desquamated epithelial cells)-5. Skin Test-6. RAST test.

used to monitor a person's ability to breathe out air.

Reduced when airways are constricted.

Curschman’s spirals

Charcot-Leyden crystals

THE END